Esperion Therapeutics, Inc. (ESPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 769.1M |
| Enterprise Value | 1.15B |
| P/E Ratio | -130.58 |
| PEG Ratio | -0.4 |
| Price/Sales Ratio | 1.57 |
| Price/Book Ratio | -2.58 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | 18.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.02 |
| Operating Margin | 0.18 |
| Return On Assets | -0.02 |
| Return On Equity | 0.02 |
| Revenue | 403.14M |
| Revenue/Share | 1.66 |
| Gross Profit | 273.91M |
| EBITDA | 63.87M |
| Net Income | -22.68M |
| Diluted EPS | -0.11 |
| Total Cash | 156.16M |
| Total Cash/Share | 0.62 |
| Total Debt | 252.63M |
| Total Debt/Equity | -0.82 |
| Current Ratio | 1.53 |
| Book Value Per Share | -1.23 |
| 52-Week Change | 203.85 |
| 52-Week High | 4.18 |
| 52-Week Low | 0.95 |
| Moving Average 50 Days | 2.8 |
| Moving Average 200 Days | 3.02 |
| Average Volume | 12.87M |
| Shares Outstanding | 207.91M |
| % Held by Institutions | 83.9 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |